CS
TNXP icon

Credit Suisse’s Tonix Pharmaceuticals TNXP Stock Holding History

Credit Suisse’s Portfolio TNXP Stock Details TNXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Hold
0
– -$9K – 4314
2022
Q1 		– Hold
0
– – – 3546
2021
Q4 		– Hold
0
– – – 4447
2017
Q1 		– Hold
0
– -$7K – 4055
2016
Q4 		– Hold
0
– – – 4071
2016
Q3 		– Hold
0
– – – 4022
2016
Q2 		– Hold
0
– – – 4037
2016
Q1 		– Hold
0
– – – 3828
2015
Q4 		– Hold
0
– – – 4097
2015
Q3 		– Hold
0
– -$225K – 4473
2015
Q2 		– Hold
0
– – – 4167
2014
Q1 		– Hold
0
– -$200K – 4843
2013
Q4 		– Hold
0
– – – 4333

Other funds holding TNXP

M
Murchinson Toronto, Ontario, Canada $725M AUM 82.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return